High Tumour Cannabinoid CB₁ Receptor Immunoreactivity Negatively Impacts Disease-Specific Survival in Stage II Microsatellite Stable Colorectal Cancer

• Sofia B. Gustafsson,

  Affiliation Department of Pharmacology and Clinical Neuroscience, Pharmacology, Umeå University, Umeå, Sweden

  ⨯
• Richard Palmqvist,

  Affiliation Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden

  ⨯
• Maria L. Henriksson,

  Affiliation Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden

  ⨯
• Anna M. Dahlin,

  Affiliation Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden

  ⨯
• Sofia Edin,

  Affiliation Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden

  ⨯
• Stig O. P. Jacobsson,

  Affiliation Department of Pharmacology and Clinical Neuroscience, Pharmacology, Umeå University, Umeå, Sweden

  ⨯
• Åke Öberg,

  Affiliation Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden

  ⨯
• Christopher J. Fowler

  * E-mail: cf@pharm.umu.se

  Affiliation Department of Pharmacology and Clinical Neuroscience, Pharmacology, Umeå University, Umeå, Sweden

  ⨯